NewsCyrus Massoumi, ZocDoc
Aug 24, 2015 02:03 AM EDT
ZocDoc Inc. is a New York digital health scheduling company that was founded in 2007. At that time, it offers a free-of-charge medical care research facility for users by combining information about medical practices and doctors' individual schedules in a central location.
It also has offices in Arizona and India with about 600 employees. ZocDoc is free for patients and available via ZocDoc.com or the ZocDoc app for iPhone and Android.
ZocDoc is the tech company at the beginning of a better healthcare experience where each month, millions of patients use ZocDoc to find in-network neighborhood doctors, instantly book appointments online, see what real patients have to say, get reminders for upcoming appointments and preventive checkups, fill out the paperwork online and a lot more.
Self-described as "the beginning of a better healthcare experience for millions of patients every month" the company claims to work "to fix broken systems that get in the way of good care by uniting modern patients and doctors."
ZocDoc founder and Chief Executive Officer Cyrus Massoumi said in a statement that, "Since our inception, we've been working to lead the healthcare experience into the digital age, and this funding will help us continue to deliver on our mission to give power to the patient ."
Now it has raised a large sum of $130 million round led by Baillie Gifford and Atomico which is going to be used for expansion. The proceeds will be used to develop products and expand beyond its scheduling capability.
Although the company doesn't break out specific figures, their footprint in the US covers 60% of the population with the often repeated claim that "millions of patients" are using the service to book more than 1,800 different types of procedures across more than 50 different medical specialties.
The company said it would use the new round to more heavily invest in developing products that sit on top of their core marketplace and extend beyond its hallmark scheduling capability.